Manglicmot, Solidad D.

HRN: 28-86-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2026
CEFTAZIDIME 1GM (VIAL)
06/10/2026
06/16/2026
IV
2gm
Q8
Bacterial Peritonitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: